TABLE 5.
Numbers of errors and discrepancies between MICs obtained by commercial techniques and the CLSI reference procedure after 48 h of incubation, by antifungal agent
| Antifungal agenta | No. of errors or discrepancies between CLSI48H andb: |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vitek |
Etest |
SYOne |
|||||||||||||
| VME | ME | MiE | SD | NSD | VME | ME | MiE | SD | NSD | VME | ME | MiE | SD | NSD | |
| AMB | 0 | 0 | 0 | 8 | 0 | 10 | |||||||||
| 5FC | 1 | 0 | 14 | 0 | 1 | 23 | 0 | 0 | 16 | ||||||
| FLZ | 3 | 0 | 25 | 1 | 0 | 33 | 1 | 0 | 30 | ||||||
| VOR | 2 | 2 | 2 | 0 | 1 | 5 | 0 | 1 | 5 | ||||||
| Total | 6 | 2 | 41 | 0 | 0 | 1 | 2 | 61 | 0 | 8 | 1 | 1 | 51 | 0 | 10 |
a
AMB, amphotericin B; 5FC, flucytosine; FLC, fluconazole; VRC, voriconazole.
b
Vitek, Vitek 2 system technique; CLSI48H, CLSI reference procedure after 48 h of incubation; Etest, Etest method; SYOne, Sensititre YeastOne technique; VME, very major errors; ME, major errors; MiE, minor errors; SD, substantial discrepancies; NSD, nonsubstantial discrepancies.